Last reviewed · How we verify

NCT03506217

Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair

Status unknown Last updated 24 April 2018
What this trial tests

trial testing Vigileo Flo-trac device in Mitral Valve Prolapse in 13 participants. Status unknown.

Timeline
1 May 2018
Primary endpoint
1 August 2018
1 January 2019

Quick facts

Lead sponsorSakarya University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment13
Start date1 May 2018
Primary completion1 August 2018
Estimated completion1 January 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sakarya University

Who can join

Adults 18 to 65, any sex, with Mitral Valve Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Minimally invasive transapical off-pump chordae implantation includes features such as tachycardia, arrhythmia, hemorrhage, sudden hemodynamic changes caused by the device moving in the left ventricle and the atrium, for anesthetists. In this observational study, the investigators presented the investigators's hemodynamic recuperation and anesthesia experiences revealed by cardiac output measurement after transapical mitral valve repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mitral Valve Prolapse

Currently open trials in the same condition.

Other Sakarya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03506217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing